About
Molecular Diagnostics, Sequencing
Areas of Focus
Categories
Genetics & GenomicsSouthwestern U.S.
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
140
By Phase
NA: 3
By Status
UNKNOWN: 2WITHDRAWN: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05422144Collaborator
Cleanser for Acute Wounds
NAWithdrawn
Started: Jan 1, 2024 · Completed: Apr 30, 2025
NCT05276466Lead Sponsor
Assessment of Urinary Polymerase Chain Reaction (PCR) and Next Generation Sequencing (NGS) Technology in the Evaluation and Management of Females With Chronic Bladder Pain and Cystitis-like Symptoms
NAUnknown
100 participants
Started: Feb 1, 2022 · Completed: Dec 15, 2023
NCT05287438Lead Sponsor
Next Generation Sequencing Versus Traditional Cultures for Clinically Infected Penile Implants: Impact of Culture Identification on Outcomes
NAUnknown
40 participants
Started: Oct 27, 2021 · Completed: Oct 31, 2024
Funding History (1)
D
Apr 17, 2017
Locations (1)
Headquarters
Lubboick, TX, United States
Map
Loading map...